SEC Form 4 · accession 0001209191-16-133852

Audentes Therapeutics, Inc. · BOLD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Thomas Woiwode

Director

Period of report

Jul 25, 2016

Accepted (ET)

Jul 25, 2016 · 5:09 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001628738

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jul 25, 2016	C	1,081,477	—	A	1,081,477	I	By Versant Venture Capital IV, L.P.
Common Stock^F3,F2	Jul 25, 2016	C	480,856	—	A	1,562,333	I	By Versant Venture Capital IV, L.P.
Common Stock^F4,F2	Jul 25, 2016	C	198,410	—	A	1,760,743	I	By Versant Venture Capital IV, L.P.
Common Stock^F1,F5	Jul 25, 2016	C	6,811	—	A	6,811	I	By Versant Side Fund IV, L.P.
Common Stock^F3,F5	Jul 25, 2016	C	3,029	—	A	9,840	I	By Versant Side Fund IV, L.P.
Common Stock^F4,F5	Jul 25, 2016	C	1,249	—	A	11,089	I	By Versant Side Fund IV, L.P.
Common Stock^F2	Jul 25, 2016	P	34,781	$15.00	A	1,795,524	I	By Versant Venture Capital IV, L.P.
Common Stock^F5	Jul 25, 2016	P	219	$15.00	A	11,308	I	By Versant Side Fund IV, L.P.

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series A Preferred Stock^F1,F2	—	Jul 25, 2016	C	1,081,477	D	—	—	Common Stock	1,081,477	I
Series B Preferred Stock^F3,F2	—	Jul 25, 2016	C	480,856	D	—	—	Common Stock	480,856	I
Series C Preferred Stock^F4,F2	—	Jul 25, 2016	C	198,410	D	—	—	Common Stock	198,410	I
Series A Preferred Stock^F1,F5	—	Jul 25, 2016	C	6,811	D	—	—	Common Stock	6,811	I
Series B Preferred Stock^F3,F5	—	Jul 25, 2016	C	3,029	D	—	—	Common Stock	3,029	I
Series C Preferred Stock^F4,F5	—	Jul 25, 2016	C	1,249	D	—	—	Common Stock	1,249	I

Explanation of responses

F1Each share of the issuer's Series A Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-208842) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.
F2These securities are held of record by Versant Venture Capital IV, L.P. ("VVC IV"). Versant Ventures IV, LLC ("VV IV") is the sole general partner of VVC IV. The reporting person, together with each of Brian Atwood, Bradley Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk Nielsen, Robin Praeger, Rebecca Robertson and Charles Warden, are directors or members of VV IV and may be deemed to share voting and dispositive power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F3Each share of the issuer's Series B Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.
F4Each share of the issuer's Series C Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.
F5These securities are held of record by Versant Side Fund IV, L.P. ("VSF IV"). VV IV is the sole general partner of VSF IV. The reporting person, together with each of Brian Atwood, Bradley Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk Nielsen, Robin Praeger, Rebecca Robertson and Charles Warden, are directors or members of VV IV and may be deemed to share voting and dispositive power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.